Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Pemoline · 1 trial · 1 indication
| Name | Type | Description |
|---|---|---|
| Pemoline | DRUG | - |
Please contact site for information.
Pemoline is an investigational small molecule being studied for the treatment of Cocaine-Related Disorders. It is currently in Phase 2 clinical development, though the single completed trial did not report enrollment numbers.
Pemoline is being developed by National Healthcare Corp. (NHC). The company is conducting clinical research on this small molecule for Cocaine-Related Disorders.
Pemoline is in Phase 2 clinical development. One Phase 2 trial has been completed, and there are no active trials currently ongoing for this drug.
Pemoline has one completed clinical trial, NCT00000282, titled 'Pemoline for Cocaine Abuse - 7'. This Phase 2 study was conducted in the United States and enrolled adults with Cocaine-Related Disorders.
Pemoline is not FDA approved. It is an investigational drug currently in Phase 2 clinical development for Cocaine-Related Disorders, and its safety and efficacy have not been established.